Evidence map›Paper›PMID 41711828›Full record

Observational studyJournal of neural transmission (Vienna, Austria : 1996)2026

Hyposmia as a predictor of cognitive decline in long-term Parkinson's disease with dementia: a multicenter study in China.

Hualong Wang, Wanlin Li, Yan Ding, Qian Sun, Jin Liu, Shishuang Cui, Gen Li, Chao Gao, Robert Chen, Xiaoyun Liu and 2 more

Abstract readMulticenter StudyObservational Study
PubMed Publisher
In one paragraph

Observational study in Journal of neural transmission (Vienna, Austria : 1996), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Hualong Wang *Department of Neurology and Institute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. wanghualong@renji.com.
Wanlin Li *Department of Neurology, The First Hospital of Hebei Medical University, Brain Aging and Cognitive Neuroscience Laboratory of Hebei Province, Shijiazhuang, 050031, Hebei, China.
Yan Ding *Department of Neurology, Xuanwu Hospital Capital Medical University, Beijing, China.
Qian SunDepartment of Neurology and Institute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Jin LiuDepartment of Neurology and Institute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Shishuang CuiDepartment of Neurology and Institute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Gen LiDepartment of Neurology and Institute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Chao GaoDepartment of Neurology and Institute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Robert ChenDivision of Neurology, Department of Medicine, University of Toronto, Toronto, ON, Canada.
Xiaoyun LiuDepartment of Neurology, The First Hospital of Hebei Medical University, Brain Aging and Cognitive Neuroscience Laboratory of Hebei Province, Shijiazhuang, 050031, Hebei, China. 57404217@hebmu.edu.cn.
Gang WangDepartment of Neurology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. wanggang@renji.com.
Shengdi ChenDepartment of Neurology and Institute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. chensd@rjh.com.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dementia is one of the most significant non-motor symptoms in Parkinson's disease (PD), particularly in the advanced stages. Identifying predictive factors for cognitive decline in PD is crucial for optimizing intervention strategies, improving prognosis. However, few studies have focused on long-term PD (L-PD) patients with dementia (L-PDD). A total of 330 PD patients were recruited from the movement disorder clinics at three tertiary hospitals in China. The cohort included 201 long-term PD patients without dementia (L-PDN) and 66 L-PDD patients with disease duration greater than 10 years, as well as 63 patients with short-term PDD (S-PDD) with disease duration less than 10 years. Data on demographic and clinical characteristics were collected. T-test and Mann-Whitney U test, Spearman's correlation, and stepwise multiple linear regression were employed for data analysis. The average disease duration, age at interview and age of onset of the L-PD patients were 13.19 ± 3.43, 66.46 ± 7.81 and 53.26 ± 8.41 years, respectively. And the average disease duration, age at interview and age of onset of the S-PDD patients were 4.41 ± 2.48, 66.97 ± 7.88 and 62.56 ± 8.00 years. Compared with L-PDN, L-PDD patients had more advanced motor and non-motor symptoms including severe hyposmia, lower education level, which constructed a good linear regression model with the variable of dementia. In the L-PDD group, MMSE scores were correlated with both education duration and SS-16 scores (16-item odor identification test of Sniffin' Sticks). However, no significant correlation between SS-16 scores and MMSE scores was observed in either the L-PDN or S-PDD groups, despite the presence of severe hyposmia in the S-PDD group. The present study suggests that lower education levels and hyposmia are risk factors for L-PDD, with the severity of hyposmia potentially correlating with both the development of PDD and the degree of cognitive impairment in L-PDD.

Indexed as

Cognitive DysfunctionDementiaOlfaction DisordersParkinson DiseaseAgedChinaFemaleHumansMaleMiddle AgedNeuropsychological TestsCognitive impairmentDementiaHyposmiaNon-motor symptomsParkinson's disease

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.